Mithat Gönen

Memorial Sloan Kettering Cancer Center — United States

Medicine · Health Sciences

156h-index101.0kcitations1.3kworks5.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis(221), Pancreatic and Hepatic Oncology Research(208), Cholangiocarcinoma and Gallbladder Cancer Studies(183), Cancer Genomics and Diagnostics(130), Colorectal Cancer Treatments and Studies(127)

Publications1.3k total

Risk of Residual Cancer After Immediate Surgery or Nonoperative Management After Malignant Colorectal Polypectomy With High-Risk Features
JCO oncology advances.·2025Open Access
Clustering‐Informed Shared‐Structure Variational Autoencoder for Missing Data Imputation in Large‐Scale Healthcare Data
Statistics in Medicine·2025
Postoperative Pancreatic Fistula After Pancreatoduodenectomy
Annals of Surgery·2025
Evaluating post-T-DXd treatment strategies in HER2-positive metastatic breast cancer
Breast Cancer Research and Treatment·2025Open Access
Supplementary Figure from Accounting for Delayed Entry in Analyses of Overall Survival in Clinico-Genomic Databases
2025Open Access
Supplementary Figure from Accounting for Delayed Entry in Analyses of Overall Survival in Clinico-Genomic Databases
2025Open Access
Supplementary Figure from Accounting for Delayed Entry in Analyses of Overall Survival in Clinico-Genomic Databases
2025Open Access
Supplementary Figure from Accounting for Delayed Entry in Analyses of Overall Survival in Clinico-Genomic Databases
2025Open Access
Supplementary Figure from Accounting for Delayed Entry in Analyses of Overall Survival in Clinico-Genomic Databases
2025Open Access
Supplementary Data from Accounting for Delayed Entry in Analyses of Overall Survival in Clinico-Genomic Databases
2025Open Access
Data from Accounting for Delayed Entry in Analyses of Overall Survival in Clinico-Genomic Databases
2025Open Access
ASO Visual Abstract: Outcomes of First-versus Second-Line Hepatic Artery Infusion Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma
Annals of Surgical Oncology·2025
ASO Visual Abstract: Hepatic Recurrence Rate Based on Extent of Adjuvant Floxuridine Exposure After Resection of Colorectal Liver Metastases
Annals of Surgical Oncology·2025
Provider billing margin and cancer treatment selection: population based cohort study
BMJ·2025· 1 citedOpen Access
The simple c-reactive protein (CRP) to albumin ratio (CAR) stratifies treatment response and survival following chimeric antigen receptor T-cell therapy for non-Hodgkin's lymphoma
Blood·2025Open Access
Impact of holding therapy prior to apheresis on outcomes following CD19 CAR-T cell therapy in large B-cell lymphoma
Blood·2025
Long-term cardiovascular outcomes in patients with lymphoma who had early post-CAR-T cardiovascular events: A multi-center, international study
Blood·2025Open Access
Effectiveness of second-line therapies following upfront daratumumab plus bortezomib, cyclophosphamide and dexamethasone: A new benchmark
Blood·2025
Hepatic Recurrence Rate Based on Extent of Adjuvant Floxuridine Exposure After Resection of Colorectal Liver Metastases
Annals of Surgical Oncology·2025
One-Year Mortality after Hepatectomy: Defining a Novel Quality Metric
Annals of Surgical Oncology·2025· 1 cited
page 1 of 68Next →

Frequent Co-authors

Ronald P. DeMatteo(16), William R. Jarnagin(14), Yuman Fong(12), Leslie H. Blumgart(10), Michael I. D’Angelica(8), Michel Sadelain(7), Murray F. Brennan(7), Peter J. Allen(6), Steven M. Larson(6), Andrea Cercek(5), Jinru Shia(5), Leonard B. Saltz(5), J. Joshua Smith(4), Isabelle Rivière(4), Renier J. Brentjens(4), Rona Yaeger(4), Julio García‐Aguilar(4), Marc J. Gollub(4), Martin R. Weiser(4), Heiko Schöder(4)